Paul M. Weiss is Director at ALFACELL CORP (ACEL). They have made 2 open-market trades across 2 companies since 2007, most recently 2017-03-15.
CIK 0001217588
2 open-market purchases totalling $1.4M since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACEL | 24,955 | $272K |
| PrivateUnlisted | 1,576,167 | — |
| Total | $272K |
Shares reported on the most recent Form 4, priced at the 2017-03-17 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PrivateAerpio Pharmaceuticals, Inc. | BUY | 2017-03-15 | 2017-03-17 | $5.00 | $1.4M | N/A | N/A | N/A |
| ACEL | BUY | 2007-10-19 | 2007-10-19 | $1.99 | $25K | -0.5% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.